Skip to content
10-Q

Quarterly Report

Regenicin, Inc.

0001662252-22-000025

← back to feed
Filed
May 23, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · May 13, 2022 153.48M sh
Shares Diluted Q2 2022 · Mar 31, 2022 153.48M sh
Shares Diluted Q2 2022 · Mar 31, 2022 153.48M sh
Shares Diluted Q2 2022 · Mar 31, 2021 153.48M sh
Shares Diluted Q2 2022 · Mar 31, 2021 153.48M sh
Operating Cash Flow Q2 2022 · Mar 31, 2022 −$17.15K
Operating Cash Flow Q2 2022 · Mar 31, 2021 −$12.54K
Stockholders Equity Q2 2022 · Mar 31, 2022 −$5.28M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$4.29M
Stockholders Equity Q2 2022 · Sep 30, 2021 −$4.96M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$4.68M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$4.45M
Stockholders Equity Q2 2022 · Sep 30, 2020 −$4.29M
Current Liabilities Q2 2022 · Mar 31, 2022 $5.28M
Current Liabilities Q2 2022 · Sep 30, 2021 $4.96M
Total Assets Q2 2022 · Mar 31, 2022 $3.69K
Total Assets Q2 2022 · Sep 30, 2021 $4.61K
Eps Diluted Q2 2022 · Mar 31, 2022 $0.00
Eps Diluted Q2 2022 · Mar 31, 2022 $0.00
Eps Diluted Q2 2022 · Mar 31, 2021 $0.00
Eps Diluted Q2 2022 · Mar 31, 2021 $0.00
Eps Basic Q2 2022 · Mar 31, 2022 $0.00
Eps Basic Q2 2022 · Mar 31, 2022 $0.00
Eps Basic Q2 2022 · Mar 31, 2021 $0.00
Eps Basic Q2 2022 · Mar 31, 2021 $0.00
Sga Expense Q2 2022 · Mar 31, 2022 $155.51K
Sga Expense Q2 2022 · Mar 31, 2022 $302.05K
Sga Expense Q2 2022 · Mar 31, 2021 $225.74K
Sga Expense Q2 2022 · Mar 31, 2021 $376.55K
Net Income Q2 2022 · Mar 31, 2022 −$166.65K
Net Income Q2 2022 · Mar 31, 2022 −$320.77K
Net Income Q2 2022 · Dec 31, 2021 −$154.13K
Net Income restated Q2 2022 · Mar 31, 2021 −$233.3K
Net Income restated Q2 2022 · Mar 31, 2021 −$393.18K
Net Income Q2 2022 · Dec 31, 2020 −$159.88K
Operating Income Q2 2022 · Mar 31, 2022 −$155.51K
Operating Income Q2 2022 · Mar 31, 2022 −$302.05K
Operating Income Q2 2022 · Mar 31, 2021 −$225.74K
Operating Income Q2 2022 · Mar 31, 2021 −$376.55K